Prefilled Syringes Market Revenue to Cross USD 4,972 million by 2035

According to a recently published report by Roots Analysis, the growing preference of patients towards home healthcare and ongoing technological advancements in the prefilled syringes formats are driving the prefilled syringes market.

Prefilled Syringes Industry Overview

The global Prefilled Syringes market is anticipated to grow at a CAGR of 4.6% from 2024-2035, reaching USD 4,972 million by 2035.

Prefilled syringes are the devices that are already filled with a specific medication and eliminate the requirement of manually filling the drug into the delivery device. These drug delivery devices have gained significant traction in the healthcare domain, owing to the various advantages offered by them, including user-friendly nature, enhanced accuracy in dosing and improved medication adherence. They are highly versatile products, in terms of administering different types of drugs, including complex biologics, insulin, vaccines and other injectable medications. Further, they can be customized to meet specific pharmaceutical and patient needs. Prefilled syringes also help maintain stability of sensitive formulations by safeguarding them from environmental conditions during storage.

Browse 445 figures and 710 market data tables spread across 867 pages and detailed Table of Content on “Prefilled Syringes Market by Purpose of Syringe, Type of Molecule (specific to Therapeutic Syringes), Therapeutic Area (specific to Therapeutic Syringes), Type of Barrel Material, Number of Chamber, Type of Needle System, Usability of Syringe, Type of Syringe, Type of Packaging and Key Geographical Regions: Industry Trends and Global Forecasts” here: https://www.rootsanalysis.com/reports/prefilled-syringes-market/284.html

Market Drivers

Several factors are propelling the growth of the prefilled syringes market. With increasing prevalence of chronic diseases (such as diabetes, heart diseases and rheumatoid arthritis), there has been an increase in the demand for reliable and convenient drug delivery systems, such as prefilled syringes. Another factor is the rising demand for biopharmaceuticals (such as monoclonal antibodies and vaccines), that need to be stored in devices that maintain product integrity and prevent microbial contamination. Additionally, there has been an increasing preference for self-injection devices by end users, for medications that require dosing at frequent intervals and deliver drugs useful in treating chronic conditions.

Market Restraints

While the PFS market is experiencing substantial growth, there are some challenges for the stakeholders in this domain. One of the major factors is the stringent regulatory requirements, impacting the development and approval process of the prefilled syringes. Although prefilled syringes are simpler to use than conventional vials, high cost is required to set up manufacturing facilities and specialized equipment. Further, it is also essential for the manufacturers to ensure sterility and stability of the drug, as well its compatibility with the syringe material, which increases the complexity and cost of the overall manufacturing process.

Growth Factors

Despite the aforementioned challenges, various growth factors continue to drive the prefilled syringes market forward. One of the primary factors include the ongoing innovation in materials and technological advancements to increase safety and compatibility of the prefilled syringe; notably, various safety systems (either add-on devices or integrated) have been incorporated into prefilled syringes to prevent needle stick injuries. Further, prefilled syringes are increasingly being integrated with advanced injection devices, such as autoinjectors and pen injectors; this enables the pharmaceutical companies to extend the lifecycle of their products.

Prefilled Syringes Market Segments

Based on the purpose of syringe, the market is segmented into cosmetic prefilled syringes, specialty prefilled syringes and therapeutic prefilled syringes.

• The specialty prefilled syringes segment led the market for prefilled syringes, capturing the largest revenue share of close to 47% in 2024.
• The cosmetic prefilled syringes segment of the pre filled syringe market is anticipated to show highest growth rate of over 6% during the forecast period.

Based on the type of molecule, the therapeutic prefilled syringes market is segmented into antibodies, cell therapies, peptides, proteins, small molecules and vaccines.

• The protein segment led the market for therapeutic prefilled syringes, capturing the largest revenue share of 50% in 2024.
• The cell therapies segment of the pre filled syringe market is anticipated to show highest growth rate of around 13% during the forecast period.

Based on the therapeutic area, the therapeutic prefilled syringes market is segmented into autoimmune disorders, blood disorders, cardiovascular disorders, infectious diseases, metabolic disorders, neurological disorders, oncological disorders, ophthalmic disorders, orthopedic disorders, respiratory disorders and other disorders.

• The blood disorders led the market for therapeutic prefilled syringes, capturing the largest revenue share of around 65% in 2024.
• The oncological disorders segment of the pre filled syringe market is anticipated to show the highest growth rate of 6.8% during the forecast period.

Based on the type of barrel material, the market is segmented into glass prefilled syringes and plastic prefilled syringes.

• The glass prefilled syringes segment led the market for prefilled syringes, capturing the largest revenue share of 92% in 2024.
• The plastic prefilled syringes segment of the pre filled syringe market is anticipated to show the highest growth rate of around 13% during the forecast period.

Based on the number of chamber, the market is segmented into dual chamber prefilled syringes and single chamber prefilled syringes.

• The single chamber prefilled syringes segment led the market for prefilled syringes, capturing the largest revenue share of 71% in 2024.
• The dual chamber prefilled syringes market segment is anticipated to show the highest growth rate of 6.8% during the forecast period, in the pre filled syringe market.

Based on the type of needle system, the market is segmented into luer prefilled syringes and staked needle prefilled syringes

• The staked needle prefilled syringes segment led the market for prefilled syringes, capturing the largest revenue share of 60% in 2024.
• The luer prefilled syringes segment is anticipated to show the highest growth rate of more than 5% during the forecast period, in the prefilled syringe market.

Based on the usability of syringe, the market is segmented into disposable prefilled syringes and reusable prefilled syringes

• The disposable prefilled syringes segment led the market for prefilled syringes, capturing the largest revenue share of around 80% in 2024.
• The reusable prefilled syringes segment is anticipated to show the highest growth rate of around 10% during the forecast period, in the prefilled syringe market.

Based on the type of syringe, the market is segmented into conventional prefilled syringes and safety prefilled syringes

• The safety prefilled syringes segment led the market for prefilled syringes, capturing the largest revenue share of around 70% in 2024.
• The safety prefilled syringes segment is anticipated to show the highest growth rate of 6.5% during the forecast period, in the prefilled syringe market.

Based on the type of packaging, the market is segmented into bulk prefilled syringes and nested prefilled syringes

• The nested prefilled syringes segment led the market for prefilled syringes, capturing the largest revenue share of around 80% in 2024.
• The nested prefilled syringes segment is anticipated to show the highest growth rate of 5% during the forecast period, in the prefilled syringe market.

Based on the Regional Insights, the market is segmented North America, Europe, Asia Pacific, Middle East and North Africa, and Latin America

• Europe dominated the PFS market and accounted for the largest revenue share of close to 50% in 2024.
• In Asia Pacific, the PFS market is anticipated to demonstrate considerable growth during the forecast period.

Key Companies Profiled

The prefilled syringes market report also includes detailed profiles of key players (listed below) that manufacture prefilled syringes:

• Becton and Dickinson
• Credence MedSystems 
• Gerresheimer 
• J O Pharma
• Medefil
• MedXL
• Mitsubishi Gas Chemical
• Nipro PharmaPackaging
• Novartis
• Pfizer
• SCHOTT 
• Shandong Pharmaceutical Glass
• Shandong Weigao 
• Shin Yan Sheno Precision Industrial 
• Stevanato 
• Taisei Kako
• Vetter Pharma
• West Pharmaceutical

You Can Download Free Sample PDF Copy of This Report at:
https://www.rootsanalysis.com/reports/prefilled-syringes-market/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in market research, competitive intelligence and consulting services. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com